Water-based 'engine' propels tumor cells through tight spaces in the body

April 30, 2014
This is an illustration of the newly discovered mechanism by which cancer cells are able to spread disease throughout the body. Credit: Martin Rietveld/JHU

Johns Hopkins researchers have discovered a new mechanism that explains how cancer cells spread through extremely narrow three-dimensional spaces in the body by using a propulsion system based on water and charged particles.

The finding, reported in the April 24 issue of the journal Cell, uncovers a novel method the deadly use to migrate through a cancer patient's body. The discovery may lead to new treatments that help keep the disease in check. The work also points to the growing importance of studying how cells behave in three dimensions, not just atop flat two-dimensional lab dishes.

Based on such lab dish studies, cancer researchers had concluded that require actin and other proteins to form arm-like extensions to "crawl" across the flat surfaces. This type of travel was believed to be the primary means of how cancer spreads within a patient, a process called metastasis. Based on this conclusion, researchers have been working on ways to disable actin and its molecular helpers, hoping this can keep cancer from spreading.

But in a study published in 2012, a Johns Hopkins team led by Konstantinos Konstantopoulos, chair of the Department of Chemical and Biomolecular Engineering, found that tumor cells could move through narrow spaces without using actin and its biochemical partners.

The video will load shortly

"That was a stunning discovery, not in line with the prevailing beliefs about how cells migrate," Konstantopoulos said. "So we wanted to figure out exactly how the tumor cells were able to move through these spaces without relying on actin."

He collaborated with Sean X. Sun, a Johns Hopkins associate professor of mechanical engineering with experience in math modeling and physics at microscopic levels.

"The mystery we needed to solve," Sun said, "was how the cells in these confined spaces could still move when you took away their usual 'engine,' the actin."

Kostantopoulos said Sun and Hongyuan Jiang, a postdoctoral fellow working in Sun's lab, "came up with a phenomenal mathematical model that provided insights into how the cells might use a different system to travel." Then Konstantopoulos and other team members, including Kimberly Stroka, a postdoctoral fellow in his own lab, used a microfluidic lab-on-a-chip and imaging techniques to conduct experiments establishing the new mechanism of migration proposed by Sun and Jiang's model. The tests utilized human and animal cancer cells. Stroka and Jiang were designated co-lead authors of the resulting journal article.

As reported in the article, the tumor cells' new "engine" turned out to be a combination of sodium-hydrogen ions, cell membrane proteins called aquaporins, and water. The researchers found that within tight spaces, create a flow of liquid that takes in water and ions at a cell's leading edge and pumps them out the trailing edge, propelling the cell forward. In the actin-dependent migration model, the cell is pushed forward by the biochemical equivalent of a boat engine. The water-based mechanism, the researchers said, more closely resembles the way a sailboat is thrust ahead by gusts of wind. The team called this mechanism the Osmotic Engine Model.

"This discovery is important because it reveals one reason why some diseases like cancer don't always respond to certain treatments," Konstantopoulos said. Sun added, "It's because these diseases have redundant mechanisms—more than one method—for migrating through the body."

Explore further: Cancer cells don't take 'drunken' walks through the body

Related Stories

Cancer cells don't take 'drunken' walks through the body

March 11, 2014
Because of results seen in flat lab dishes, biologists have believed that cancers cells move through the body in a slow, aimless fashion, resembling an intoxicated person who cannot walk three steps in a straight line. This ...

New study shows insight into breast cancer cell migration

October 29, 2013
(Medical Xpress)—A new study by University of Kentucky Markey Cancer Center researchers Min Chen and Kathleen O'Connor shows that a specific protein may assist breast cancer cells in metastasizing.

p53 cuts off invading cancer cells

March 24, 2014
The tumor suppressor p53 does all it can to prevent oncogenes from transforming normal cells into tumor cells by killing defective cells or causing them to become inactive. Sometimes oncogenes manage to initiate tumor development ...

Spread of cancer cells may be slowed by targeting of protein

December 18, 2012
(Medical Xpress)—The spread of cancer cells may be slowed by targeting the protein km23-1, according to researchers at Penn State College of Medicine.

Recommended for you

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.